Vista Pharmaceuticals share news and announcements
BSE: 524711Pharmaceuticals & BiotechnologySmall Cap
Share price at the BSE close on 23 Oct 2026. Previous close ₹5.48.
- Market capMarket capitalisation. Share price times the number of shares: what the whole company is worth at the day's price. The rank is by average market value over the six months to Jun 2026, among listed companies.
- ₹36 Cr3,508th largest listed
- P/EPrice to earnings, trailing. Market cap divided by the profit of the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, after the share of the other owners of its subsidiaries: what investors pay for each rupee of a year's profit.
- Lossover the last 12 months
- P/BPrice to book. Market cap divided by the net worth that belongs to the company's own shareholders, its assets less everything it owes and less the other owners' share of its subsidiaries, on its latest balance sheet. The filing of 29 May 2026
- 1.0
- Dividend yieldDividend yield. Dividends paid per share in the twelve months to the day, as a percentage of the day's share price.
- Nonein the last 12 months
- ROEReturn on equity. Profit over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly) that belongs to the company's own shareholders, as a percentage of their net worth, the money they have in the business. Net worth is the average of the latest balance sheet and the one a year before it. The filing of 14 Aug 2026
- −28.7%
- ROCEReturn on capital employed. Operating profit after depreciation (revenue less operating expenses and depreciation, without other income and one-off items) as a percentage of all the money the business runs on: the whole group's net worth, the other owners of its subsidiaries included, plus borrowings. Lease liabilities are not counted: the results filings do not state them. The profit is over the last twelve months (the latest four quarters, or two half years for a company that reports half-yearly); net worth and borrowings are on the latest balance sheet. The filing of 14 Aug 2026
- −32.5%
- Debt to equityDebt to equity. Borrowings divided by the whole group's net worth, the other owners of its subsidiaries included: rupees borrowed for each rupee of equity in the business. Lease liabilities are not counted: the results filings do not state them. From the balance sheet at the end of Mar 2026. The filing of 29 May 2026
- 0.27
- Volume, BSEVolume. Shares traded on the last trading day.
- 6,933
Vista Pharmaceuticals share news and announcements
532 announcements, routine notices left out, newest first. Page 9 of 11.
Jul 2017
25 Jul · Shareholding for the Period Ended June 30, 2017
Shareholding Pattern for the Period Ended June 30, 2017. For more details, kindly Click ....20 Jul · Statement Of Investor Complaints For The Quarter Ended 30Th June, 2017.
14 Jul · Shareholding for the Period Ended July 12, 2017
Shareholding Pattern for the Period Ended July 12, 2017. For more details, kindly Click ....
May 2017
Apr 2017
29 Apr · Certificate In Terms Of Regulation 40(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
20 Apr · Compliance Certificate Pursuant To Regulation 7 (3) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations, 2015 For The Half Year Ended 31St March 2017
15 Apr · Quarterly Statement On Investor Complaints Under Regulation 13 Of SEBI (Listing Obligations And Disclosure Requirements) Regulations, 2015
13 Apr · Shareholding for the Period Ended March 31, 2017
Shareholding Pattern for the Period Ended March 31, 2017. For more details, kindly Click ....10 Apr · Shareholding for the Period Ended April 10, 2017
Shareholding Pattern for the Period Ended April 10, 2017. For more details, kindly Click ....1 Apr · Results
Details of Voting results of EGM, under Regulation 44(3) of SEBI (LODR) Regulations, 2015. Kindly ....
Mar 2017
Feb 2017
Jan 2017
13 Jan · Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended December 31, 2016
10 Jan · Shareholding for the Period Ended December 31, 2016
Shareholding Pattern for the Period Ended December 31, 2016. For more details, kindly Click ....
Nov 2016
Oct 2016
16 Oct · Shareholding for the Period Ended September 30, 2016
Shareholding Pattern for the Period Ended September 30, 2016. For more details, kindly Click ....16 Oct · Statement of Investor Complaint under Reg. 13(3) of SEBI (LODR) Regulations, 2015 for Quarter ended September 30, 2016
Sep 2016